Southern Cancer Center PC-Daphne — Daphne, Alabama

Public research footprint of Southern Cancer Center PC-Daphne, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Stage II Lung Non-Small Cell Cancer AJCC v7 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIA Lung Non-Small Cell Cancer AJCC v7 · Stage IIA Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)
NCT02595944 — Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA… (Active Not Recruiting)
NCT02954874 — Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Southern Cancer Center PC-Daphne?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.